Replies to post #59623 on US Stem Cell Inc (USRM)

[nomnomnom]

yeah this stock is very comfortable rn, after this i can make my next plays bigger :]

[Track]

One of your best posts.

[CaptainObvious2017]

Love the post!!!!!!

[sorc92]

Very awesome post hippo

[pennystocKING13]

Well freaking said HH! Until last night, i assumed that all USRM is working on is the heart procedure. I found out they are using their stem cell procedures for anything even as simple as regrowing cartilage in your pinky! Basically, this company can rebuild your body! Comella has been dosing with her own stem cells for over 4 years, and she just keeps looking more and more beautiful. The stem cell dosing is reducing her inflammation and has given her vibrant youth back! See for yourselves. Just youtube Comella and compare her oldest videos to her newest videos. She looks younger than she used to. You cant fake this stuff fellas.

[BluSkies]

Also they are opening multiple clinics across the world. Europe, China, Middle East, Austria, India, Africa etc

They have partnered to open 10 clinics across the United States which will produce significant revenues. IMO

[Rubyt]

If we rmat approval, where do you see the PPS in 1 mo, 6mo, and 12 mo? I appreciate your opinion even if it's a range for these timeframes.

I see 1-2 short term, 5 mid term, and possibly 10 with a buyout long term. With rmat approval do you see more dilution or pretty much constant?

[4toSchool]

Hi HH, Great post and very much appreciated. I have just a few clarify questions. I hope that you can shed light on these as my DD hasn't yet satisfied my curiosity. I don't mind being corrected, so please provide your response. As many on this board, I want to better know what I own.

Regarding your message 59623: I am in good understanding and in full agreement with items 1,6,7,8,9,and 10. I do have questions on the remaining items 2-5.

#2 MyoCell therapy is projected to cost: "$35,000 to $45,000 range" per patient.

Any idea what share of the above reference revenue would be captured by USRM?

#3 Northstar Biotech Group LLC,

#5 Besides Patents held by Northstar, Myocell is protected by

How does USRM benefit by moving both valuable assets and 10% of future gross international revenues to Northstar. I can't help but see a possible conflict of interest in the transfer of USRM assets to Northstar, where key USRM insiders are investors.

#4 I am confident former CEO Howard L., is still involved in this

If he did have a significant interest, would that be disclosed in SEC filings? Also, wouldn't he have likely funded the small amounts of capital needed by USRM over the past few years versus seeing his interest significantly diluted by the toxic debt that they accumulated?

Does GACP "own" the stem cell storage business, at least for the next few years, and forever own all client accounts obtained through their period of "ownership"

My current understanding is that USRM stands to earn the following:

1. 33% of the profits of the one US Stem Cell Clinic in S.Florida
2. training doctors around the globe
3. selling equipment to clinics around the globe
4. I am unsure of who will benefit from licensing of patents as they may have been sold to Northstar and/or GACP. Does USRM stand to gain revenue here?

Again, your insight would be tremendously valued here, and GLTY

Go $USRM!!!!

[0001-stocks]

yes USRM is most likely very undervalued compared to other stem cell companies

[OTC_MILLIONAIR]

We got this brother